Literature DB >> 25070798

From genomics to diagnostics of esophageal adenocarcinoma.

Thomas L Vaughan1.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25070798      PMCID: PMC4324622          DOI: 10.1038/ng.3047

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


× No keyword cloud information.
  12 in total

1.  Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus.

Authors:  Kenneth K Wang; Richard E Sampliner
Journal:  Am J Gastroenterol       Date:  2008-03       Impact factor: 10.864

2.  Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma.

Authors:  Nishant Agrawal; Yuchen Jiao; Chetan Bettegowda; Susan M Hutfless; Yuxuan Wang; Stefan David; Yulan Cheng; William S Twaddell; Nyan L Latt; Eun J Shin; Li-Dong Wang; Liang Wang; Wancai Yang; Victor E Velculescu; Bert Vogelstein; Nickolas Papadopoulos; Kenneth W Kinzler; Stephen J Meltzer
Journal:  Cancer Discov       Date:  2012-08-09       Impact factor: 39.397

3.  Cost-effectiveness of endoscopic surveillance of non-dysplastic Barrett's esophagus.

Authors:  Louisa G Gordon; George C Mayne; Nicholas G Hirst; Timothy Bright; David C Whiteman; David I Watson
Journal:  Gastrointest Endosc       Date:  2013-09-27       Impact factor: 9.427

Review 4.  Cancer genome landscapes.

Authors:  Bert Vogelstein; Nickolas Papadopoulos; Victor E Velculescu; Shibin Zhou; Luis A Diaz; Kenneth W Kinzler
Journal:  Science       Date:  2013-03-29       Impact factor: 47.728

5.  Impact of endoscopic surveillance on mortality from Barrett's esophagus-associated esophageal adenocarcinomas.

Authors:  Douglas A Corley; Kunal Mehtani; Charles Quesenberry; Wei Zhao; Jolanda de Boer; Noel S Weiss
Journal:  Gastroenterology       Date:  2013-05-11       Impact factor: 22.682

Review 6.  Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis.

Authors:  Brian J Reid; Xiaohong Li; Patricia C Galipeau; Thomas L Vaughan
Journal:  Nat Rev Cancer       Date:  2010-02       Impact factor: 60.716

7.  Acceptability and accuracy of a non-endoscopic screening test for Barrett's oesophagus in primary care: cohort study.

Authors:  Sudarshan R Kadri; Pierre Lao-Sirieix; Maria O'Donovan; Irene Debiram; Madhumita Das; Jane M Blazeby; Jon Emery; Alex Boussioutas; Helen Morris; Fiona M Walter; Paul Pharoah; Richard H Hardwick; Rebecca C Fitzgerald
Journal:  BMJ       Date:  2010-09-10

8.  NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma.

Authors:  Patricia C Galipeau; Xiaohong Li; Patricia L Blount; Carlo C Maley; Carissa A Sanchez; Robert D Odze; Kamran Ayub; Peter S Rabinovitch; Thomas L Vaughan; Brian J Reid
Journal:  PLoS Med       Date:  2007-02       Impact factor: 11.069

9.  Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis.

Authors:  Jamie M J Weaver; Caryn S Ross-Innes; Nicholas Shannon; Andy G Lynch; Tim Forshew; Mariagnese Barbera; Muhammed Murtaza; Chin-Ann J Ong; Pierre Lao-Sirieix; Mark J Dunning; Laura Smith; Mike L Smith; Charlotte L Anderson; Benilton Carvalho; Maria O'Donovan; Timothy J Underwood; Andrew P May; Nicola Grehan; Richard Hardwick; Jim Davies; Arusha Oloumi; Sam Aparicio; Carlos Caldas; Matthew D Eldridge; Paul A W Edwards; Nitzan Rosenfeld; Simon Tavaré; Rebecca C Fitzgerald
Journal:  Nat Genet       Date:  2014-06-22       Impact factor: 38.330

10.  Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity.

Authors:  Austin M Dulak; Petar Stojanov; Shouyong Peng; Michael S Lawrence; Cameron Fox; Chip Stewart; Santhoshi Bandla; Yu Imamura; Steven E Schumacher; Erica Shefler; Aaron McKenna; Scott L Carter; Kristian Cibulskis; Andrey Sivachenko; Gordon Saksena; Douglas Voet; Alex H Ramos; Daniel Auclair; Kristin Thompson; Carrie Sougnez; Robert C Onofrio; Candace Guiducci; Rameen Beroukhim; Zhongren Zhou; Lin Lin; Jules Lin; Rishindra Reddy; Andrew Chang; Rodney Landrenau; Arjun Pennathur; Shuji Ogino; James D Luketich; Todd R Golub; Stacey B Gabriel; Eric S Lander; David G Beer; Tony E Godfrey; Gad Getz; Adam J Bass
Journal:  Nat Genet       Date:  2013-03-24       Impact factor: 38.330

View more
  5 in total

1.  Quantitative evaluation of in vivo vital-dye fluorescence endoscopic imaging for the detection of Barrett's-associated neoplasia.

Authors:  Nadhi Thekkek; Michelle H Lee; Alexandros D Polydorides; Daniel G Rosen; Sharmila Anandasabapathy; Rebecca Richards-Kortum
Journal:  J Biomed Opt       Date:  2015-05       Impact factor: 3.170

2.  Candidate serum metabolite biomarkers for differentiating gastroesophageal reflux disease, Barrett's esophagus, and high-grade dysplasia/esophageal adenocarcinoma.

Authors:  Matthew F Buas; Haiwei Gu; Danijel Djukovic; Jiangjiang Zhu; Lynn Onstad; Brian J Reid; Daniel Raftery; Thomas L Vaughan
Journal:  Metabolomics       Date:  2017-01-20       Impact factor: 4.290

Review 3.  The Evolving Genomic Landscape of Barrett's Esophagus and Esophageal Adenocarcinoma.

Authors:  Gianmarco Contino; Thomas L Vaughan; David Whiteman; Rebecca C Fitzgerald
Journal:  Gastroenterology       Date:  2017-07-14       Impact factor: 22.682

Review 4.  Precision prevention of oesophageal adenocarcinoma.

Authors:  Thomas L Vaughan; Rebecca C Fitzgerald
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-02-10       Impact factor: 46.802

5.  Distinct esophageal adenocarcinoma molecular subtype has subtype-specific gene expression and mutation patterns.

Authors:  Xiangqian Guo; Yitai Tang; Wan Zhu
Journal:  BMC Genomics       Date:  2018-10-24       Impact factor: 3.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.